Investigation of the effects of copper ions on protein aggregation using a model system

Cellular and Molecular Life Sciences

Volumn 61, Issue 7-8, 2004, Pages 982-991

  Capanni, C ^a   Taddei, N ^a   Gabrielli, S ^a   Messori, L ^a   Orioli, P ^a   Chiti, F ^a   Stefani, M ^a   Ramponi, G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Amyloid fibrils; Cu2+; Metal ions; Protein aggregation; Protein misfolding

Indexed keywords

ACYLPHOSPHATASE; COPPER ION; HISTIDINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONFORMATIONAL TRANSITION; EXPERIMENTAL MODEL; HOMEOSTASIS; HYDROPHOBICITY; IN VITRO STUDY; MEDICAL LITERATURE; MUSCLE; POINT MUTATION; PROTEIN AGGREGATION;

ACID ANHYDRIDE HYDROLASES; ANIMALS; COPPER; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; PROTEIN DENATURATION;

EID: 2442628158     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3447-3     Document Type: Article

References (74)

1. Kelly J. W. (1996) Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6: 11-17.
2. Dobson C. M. (2001) The structural basis of protein folding and its links with human disease. Phil. Trans. R. Soc. Lond. B 356: 133-145
3. Mattson M. P., Pedersen W. A., Duan W., Culmsee C. and Camandola S. (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann. NY Acad. Sci. 893: 154-175
4. Bellotti V., Mangione P. and Stoppini, M. (1999) Biological activity and pathological implications of misfolded proteins. Cell. Mol. Life Sci. 53: 977-991
5. Rochet J. C. and Lansbury P. T. Jr (2000) Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10: 60-68
6. Sunde M. and Blake C. C. P. (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50: 123-159
7. Serpell L. C., Sunde M., Benson M. D., Tennent G. A., Pepys M. B. and Fraser P. E. (2000) The protofilament substructure of amyloid fibrils. J. Mol. Biol. 300: 1033-1039
8. Dobson C. M. (1999) Protein misfolding, evolution and disease. Trends Biochem. Sci. 9: 329-332
9. Conway K. A., Lee S. J., Rochet J. C., Ding T. T., Williamson R. E. and Lansbury P. T. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA 97: 571-576
10. Bhatia R., Lin H. and Lal R. (2000) Fresh and nonfibrillar amyloid β protein (1-42) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP-channel-mediated cellular toxicity. FASEB J. 14: 1233-1243
11. Sousa M. M., Cardoso I., Fernandes R., Guimaraes A. and Saraiva M. J. (2001) Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy. Am. J. Pathol. 159: 1993-2000
12. Bucciantini M., Giannoni E., Chiti F, Baroni F., Formigli L., Zurdo J. et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511
13. Stefani M. and Dobson C. M. (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81: 678-699
14. Hashimoto M., Hsu L. J., Xia Y., Takeda A. M., Sundsmo M. and Masliah E. (1999) Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 10: 717-721
15. Paik S. R., Shin H. J., Lee J. H., Chang C. S. and Kim J. (1999) Copper(II)-induced self-oligomerization of alpha-synuclein. Biochem. J. 340: 821-828
16. Bush A. I., Moir R. D., Rosenkranz K. M. and Tanzi R. E. (1995) Zinc and Alzheimer's disease. Science 268: 1921-1922
17. Morgan C. J., Gelfand M., Atreya C. and Miranker A. D. (2001) Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. J. Mol. Biol. 309: 339-345
18. Jobling M. F., Huang X., Stewart L. R., Barnham K. J., Curtain C., Volitakis I. et al. (2001) Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry 40: 8073-8084
19. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., Silva H. A. de et al. (1995) The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14: 467-475
20. George J. M., Jin H., Woods W. S. and Clayton D. F. (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15: 361-372
21. Uversky V .N., Li J. and Fink A. L. (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 276: 10733-10744
22. Eliezer D., Kutluay E., Bussel R. Jr and Browne G. (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J. Mol. Biol. 307: 1061-1073
23. Baba M., Nakajo S., Tu P.-H., Tomita T., Nakaya K., Lee V. M.-Y. et al. (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152: 879-884
24. Clayton D. F. and George J. M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21: 249-254
25. Heintz N. and Zoghbi H. (1997) Alpha-synuclein - a link between Parkinson and Alzheimer diseases? Nat. Genet. 16: 325-327
26. Uversky V. N., Li J. and Fink A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein: a possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276: 44284-44296
27. Maury C. P. J. (1995) Molecular pathogenesis of beta-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Lab. Invest. 72: 4-16
28. Multhaup G., Beyreuther K. and Muller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736
29. Bush A. I., Pettingell W. H. Jr., Multhaupt G., Paradis M. D., Vonsattel J.-P., Gusella J. F. et al. (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265: 1464-1467
30. Bush A. I., Pettingell W. H. Jr., Paradis M. D. and Tanzi R. E. (1994) Modulation of A beta adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269: 12152-12158
31. Huang X., Atwood C. S., Moir R. D., Hartshorn M. A., Vonsattel J.-P., Tanzi R. E. et al. (1997) Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J. Biol. Chem. 272: 26464-26470
32. Floege J. and Ehlerding G. (1996) Beta-2-microglobulin-associated amyloidosis. Nephron 72: 9-26
33. Prusiner S. B. (1997) Prion diseases and the BSE crisis. Science 278: 245-251
34. Prusiner S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383
35. Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D. et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90: 10962-10966
36. Brown D. R., Schmidt B. and Kretzschmar H. A. (1996) Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380: 345-347
37. Jobling M. F., Stewart L. R., White A. R., McLean C., Friedhuber A., Maher F. et al. (1999) The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. J. Neurochem. 73: 1557-1565
38. Brandner S., Isenmann S., Raeber A., Fisher M., Sailer A., Kobayashi Y. et al. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379: 339-343
39. Giese A., Brown D. R., Groschup M. H., Feldmann C., Haist I. and Kretzschmar H. A. (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8: 449-457
40. Chiti F., Webster P., Taddei N., Stefani M., Ramponi G. and Dobson C. M. (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. USA 96: 3590-3594
41. Chiti F., Taddei N., Bucciantini M., White P., Ramponi G. and Dobson C. M. (2000) Mutational analysis of the propensity for amyloid formation by a globular protein. EMBO J. 19: 1441-1449
42. Chiti F., Taddei N., Baroni F., Capanni C., Stefani M., Ramponi G. et al. (2002) Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9: 137-143
43. Pastore A., Saudek V., Ramponi G. and Williams R. J. P. (1992) Three-dimensional structure of acylphosphatase: refinement and structure analysis. J. Mol. Biol. 224: 427-440
44. van Nuland N. A. J., Chiti F., Taddei N., Raugei G., Ramponi G. and Dobson C. M. (1998) Slow folding of muscle acylphosphatase in the absence of intermediates. J. Mol. Biol. 283: 883-891
45. Taddei N., Stefani M., Magherini F., Chiti F., Modesti A., Raugei G. et al. (1996) Looking for residues involved in the muscle acylphosphatase catalytic mechanism and structural stabilization: role of Asn41, Thr42, and Thr46. Biochemistry 35: 7077-7083
46. Santoro M. M. and Bolen D. W. (1988) Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry 27: 8063-8068
47. Brown D. R., Qin K., Herms J. W., Madlung A., Manson J., Strome R. et al. (1997) The cellular prion protein binds copper in vivo. Nature 390: 684-687
48. Atwood C. S., Moir R. D., Huang X., Scarpa R. C., Bacarra N. M. E., Romano D. M. et al. (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273: 12817-12826
49. Miura T., Suzuki K., Kohata N. and Takeuchi H. (2000) Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 39: 7024-7031
50. Chiti F., Stefani M., Taddei N., Ramponi G. and Dobson C. M. (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808
51. Creighton T. E. (1993) Proteins, Structure and Molecular Properties, p. 6, Freeman, New York
52. Harper J. D., Lieber C. M. and Lansbury P. T. (1997) Atomic force microscopy imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid.beta protein. Chem. Biol. 4: 951-959
53. Halliwell B. and Gutteridge J. M. C. (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219: 1-14
54. Steinberg D. (1995) Role of oxidized LDL and antioxidants in atherosclerosis. Adv. Exp. Med. Biol. 369: 39-48
55. Markesbery W. R. and Carney J. M. (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol. 9: 133-146
56. O'Connel M. J. and Peters T. J. (1987) Ferritin and haemosiderin in free radical generation, lipid peroxidation and protein damage. Chem. Phys. Lipids 45: 241-249
57. Kang J. H. and Kim S. M. (1997) Fragmentation of human Cu,Zn-superoxide dismutase by peroxidative reaction. Mol. Cells 7: 553-558
58. Kim K. S., Choi S. Y., Kwon H., Won M. H., Kang T-C and Kang J. H. (2002) The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro. Biochimie 84: 625-631
59. Chiti F., Calamai M., Taddei N., Stefani M., Ramponi G. and Dobson C. M. (2002) Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl. Acad. Sci. USA 99 (suppl. 4): 16419-16426
60. Curtain C. C., Ali F., Volitakis I. Cherny R. A., Norton R. S., Beyreuther et al. (2001) Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276: 20466-20473
61. Martins R. N., Harper C. G., Stokes G. B. and Masters C. L. (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J. Neurochem. 46: 1042-1045
62. Multhaup G., Masters C. L. and Beyreuther K. (2000) Oxidative stress in Alzheimer's desease. Alzheimer's Rep. 1: 147-154
63. Huang X., Atwood C. S., Hartshorn M. A., Multhaupt G., Goldstein L. E., Scarpa R. C. et al. (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38: 7609-7616
64. Glusker J. P. (1991) Structural aspects of metal liganding to functional groups in proteins. Adv. Prot. Chem. 42: 1-77
65. Whittal R. M., Ball H. L., Cohen F. E., Burlingame A. L., Prusiner S. B. and Baldwin M. A. (2000) Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci. 9: 332-343
66. Morita A., Kimura M. and Itokawa Y. (1994) The effect of aging on the mineral status of female mice. Biol. Trace Elem. Res. 42: 165-177
67. Zecca L., Gallorini M., Schunemann V., Trautwein A. X., Gerlach M., Riederer P. et al. (2001) Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J. Neurochem. 76: 1766-1773
68. Lovell M. A., Robertson J. D., Teedsdale W. J., Campbell J. L. and Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158: 47-52
69. Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F. and Agid Y. (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56: 446-451
70. Dexter D. T., Carayon A., Javoy-Agid F., Agid Y., Wells F. R., Daniel S. E. et al. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114: 1953-1975
71. Tanner C. M. (1989) The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 12: 49-54
72. Rybicki B. A., Johnson C. C., Uman J. and Gorell J. M. (1993) Parkinson's disease mortality and the industrial use of heavy metals in Michigan. Movement Disorders 8: 87-92
73. Gorell J. M., Johnson C. C., Rybicki B. A., Petrson E. L., Kortsha G. X., Brown G. G. et al. (1999) Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20: 239-247
74. Zayed J., Ducic S., Campanella G., Panisset J. C., Andre P., Masson H. et al. (1990) Environmental factors in the etiology of Parkinson's disease. Can. J. Neurol. Sci. 17: 286-291